Increased efflux of amyloid-β peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis.
Paganetti P., Antoniello K., Devraj K., Toni N., Kieran D., Madani R., Pihlgren M., Adolfsson O., Froestl W., Schrattenholz A. et al., 2014. Journal of Alzheimer's Disease, 38 (4) pp. 767-786. Peer-reviewed.
ici le détail